Exhibit D
JOINT FILING STATEMENT
I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the Common Stock of Celator Pharmaceuticals, Inc. is filed on behalf of each of the undersigned.
Dated: February 12, 2014
VALENCE LIFE SCIENCES GP II, LLC |
| CDK ASSOCIATES LLC | ||
|
|
| ||
|
| By: | Caxton Corporation, | |
By: | /s/ Eric W. Roberts |
|
| its Manager |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
|
| By: | /s/ Heath Weisberg | |
|
|
| Name: Heath Weisberg | |
|
|
| Title: Chief Compliance Officer | |
|
|
| ||
|
|
| ||
VALENCE CDK SPV, LP |
|
| ||
|
|
| ||
By: | VALENCE LIFE SCIENCES GP II, LLC, |
|
| |
| its General Partner |
|
| |
|
|
|
| |
By: | /s/ Eric W. Roberts |
|
| |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
|
|
|
| |
|
|
|
| |
VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P. |
| CAXTON CORPORATION | ||
|
|
| ||
By: | VALENCE LIFE SCIENCES GP II, LLC, |
|
| |
| its General Partner |
|
| |
|
| By: | /s/ Heath Weisberg | |
|
|
| Name: Heath Weisberg | |
By: | /s/ Eric W. Roberts |
|
| Title: Chief Compliance Officer |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
|
|
| ||
|
|
| ||
VALENCE ADVANTAGE LIFE SCIENCES SIDE FUND II, L.P. |
| BRUCE KOVNER | ||
|
|
| ||
By: | VALENCE LIFE SCIENCES GP II, LLC, |
|
| |
| its General Partner |
|
| |
|
| /s/ Heath Weisberg | ||
|
|
| Name: Heath Weisberg | |
By: | /s/ Eric W. Roberts |
|
| Title: Attorney-in-Fact |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
|
|
|
| |
| /s/ Eric W. Roberts |
|
| |
| ERIC W. ROBERTS |
|
| |
